Followers | 145 |
Posts | 27561 |
Boards Moderated | 3 |
Alias Born | 02/07/2004 |
Sunday, December 27, 2009 12:10:10 PM
FOR IMMEDIATE RELEASE
Contact:
David W. Moskowitz MD
CEO, GenoMed
Tel. 314.983.9938
dwmoskowitz@genomed.com
Mr. Lawrence Guyot
Editor, Guyot's Newsletter
Tel. 202-332-5157
margaretkibbee@ymail.com
ST. LOUIS—December 21, 2009—GenoMed® (OTC Pink Sheets GMED.PK), the Public Health Company™, announced today that longtime civil rights activist Lawrence Guyot has published GenoMed's story in his monthly newsletter.
The article, entitled "A Modern Day Tuskegee—and What's Really Wrong with U.S. Healthcare" (http://www.genomed.com/images/guyot_dec09nl.pdf) was written by GenoMed's CEO, David Moskowitz MD.
Mr. Guyot, one of the leaders of the civil rights movement, was born in Pass Christian, Mississippi. As a 21 year old student at Tugaloo College in 1960, he helped found SNCC, the Student Nonviolent Coordinating Committee. In 1964, Mr. Guyot directed the Freedom Summer Project in Hattiesburg, Mississippi. That same year, he was elected chairman of the Mississippi Freedom Democratic Party. He was unable to accompany the delegation to the Democratic National Convention in Atlantic City, New Jersey because he was jailed for registering black voters. The MDFP's actions in New Jersey ultimately led to the DNC desegregating future conventions and the party itself.
Mr. Guyot has been featured in a number of documentaries, including Eyes on the Prize, Making Sense of the Sixties, The War on Poverty and Tales of the FBI. In addition to his monthly newsletter, he is a frequent TV guest on CNN and Fox News.
Dr. Moskowitz said, "I am enormously proud to have such a distinguished leader of the civil rights movement stand up for me and my company, GenoMed."
Dr. Moskowitz continued, "My paper showing how to prevent at least 90% of kidney failure was published in September, 2002. Although kidney failure claims the lives of 100,000 Americans every year, it affects African-Americans 5 times more, and Hispanics 3 times more, than whites. Medicare currently spends $40 billion a year on this disease."
Dr. Moskowitz ended by saying, "Hopefully, Mr. Guyot's endorsement will spur Medicare to call me so that together we can rid our country of this awful disease."
Recent GMED News
- Globus Medical Schedules First Quarter Earnings Release and Conference Call • GlobeNewswire Inc. • 04/16/2024 08:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 10:07:51 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/01/2024 11:50:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 09:35:42 PM
- Globus Medical Reports Fourth Quarter and Full Year 2023 Results • GlobeNewswire Inc. • 02/20/2024 09:15:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 09:08:54 PM
- Globus Medical Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call • GlobeNewswire Inc. • 02/13/2024 10:17:08 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 06:08:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2024 09:45:09 PM
- Globus Medical promotes Keith Pfeil to Chief Operating Officer and Chief Financial Officer • GlobeNewswire Inc. • 02/05/2024 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2024 10:11:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2024 10:09:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2024 10:06:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2024 09:58:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2024 09:55:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2024 09:50:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2024 09:46:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2024 09:43:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2024 09:39:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2024 09:37:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2024 09:33:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/25/2024 09:52:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/10/2024 09:35:05 PM
- Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results • GlobeNewswire Inc. • 01/10/2024 09:30:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM